scholarly journals A cross sectional study on the prevalence of structural congenital anomalies among neonates delivered in a tertiary care hospital, Chennai from January 2016 to February 2017

2017 ◽  
Vol 4 (6) ◽  
pp. 2075
Author(s):  
Vinodh Muthu ◽  
Mekalai Suresh Kumar ◽  
Anitha Ram Ponnappan

Background: Congenital anomalies are important contributors to infant and childhood deaths, chronic illness and disability. The pattern and type of anomaly varies regionally. The planning and the implementation of public health programs for congenital anomalies are dependent on the prevalence data. Adequate data is unavailable in our country. The objective of this study was to study the prevalence of congenital anomalies and the factors influencing them, in Government RSRM lying in hospital, Chennai from January 2016 to February 2017.Methods: This is a cross-sectional study conducted in Government RSRM lying-in hospital, a tertiary care neonatal unit, from January 2016 to February 2017. The case records of neonates delivered during the study period were studied to identify those with congenital anomalies. The factors possibly influencing congenital anomalies were studied.Results: The number of case records analyzed was 11242, out of which 157 neonates were reported to have structural congenital anomalies; the prevalence was 1.4%. Congenital heart disease formed the majority, 46.5% (73/157) of congenital anomalies identified. The most common extra-cardiac congenital anomalies noted were cleft lip/cleft palate (15/157) 9.6%, followed by single umbilical artery which was noted in 5.7% (9/157). Down’s syndrome was seen in 3.8% (6/157) and neural tube defects in 3.2% (5/157) of the babies with congenital anomalies.Conclusions: The prevalence of commonly occurring congenital anomalies in the study hospital was comparable to the prevalence in other similar studies in India. The prevalence of neural tube defects was lower in our area compared to other countries whereas, that of acyanotic heart diseases were higher than in other studies.

2021 ◽  
pp. 63-71
Author(s):  
Kangjam Radhesana Devi ◽  
R. K. Praneshwari Devi ◽  
Jyoti Priya ◽  
Ahanthembi Sanaton ◽  
Leimapokpam Roshan Singh ◽  
...  

Author(s):  
Kangjam Radhesana Devi ◽  
R. K. Praneshwari Devi ◽  
Jyoti Priya ◽  
Ahanthembi Sanaton ◽  
Leimapokpam Roshan Singh ◽  
...  

Background: Congenital anomalies are important cause of morbidity and mortality in newborns and are defined as structural and functional abnormalities including metabolic disorders present at birth. These defects are of prenatal origin resulting from defective embryogenesis or intrinsic abnormalities in the process of development and are associated with various risk factors.Methods: Our study is a cross-sectional study done at Regional Institute of Medical Sciences, Imphal over period of one and half years from May 2016 to October 2017. Aim of study was to find out incidence of congenital anomalies and proportions of different types of congenital anomalies. Outcome was studied in relation to maternal age, religion, parity, gestational age, sex of baby, outcome and birth weight of baby.Results: Total numbers of congenital anomalies were 91 out of 13658 births. Incidence of congenital anomalies was 0.66%. Most common congenital anomaly was cleft lip (17.6%) followed by CTEV (13.2%) and was more common among male term babies. These were most common in 18-24 years of maternal age group (34.1%) followed by 30-34 years (26.4%) and among women of parity P0-P2.Conclusions: Congenital malformations are a major cause of still births and infant mortality. A level II targeted scan should be done at 18-20 weeks to find out anomalies and reduce the prevalence. There should be widespread education in the community regarding the common congenital malformations, their outcomes and possible available modes of treatment. 


2019 ◽  
Vol 6 (6) ◽  
pp. 2364
Author(s):  
Vikram V. Yaragatti ◽  
Shivanagouda .

Background: Congenital malformations are emerging as an important perinatal problem, contributing sizably to the perinatal mortality with considerable repercussions on the mothers and the families. Patients with multiple congenital anomalies present a relatively infrequent but tremendously difficult challenge to the pediatrician. Authors objective was to study the incidence of clinically detectable congenital malformations among consecutive births in hospital deliveries examined during hospital stay.Methods: A prospective cross sectional study was conducted in Department of Pediatrics at Dr R N Cooper Municipal General Hospital, Mumbai from June 2016 to June 2017. All live births from June 2016 to June 2017 were considered in the studyResults: The total number of deliveries in our hospital were 3120(100%) and the total number of babies with congenital anomaly were 43(1.4%), So the incidence of congenital anomalies amongst study population was 1.4%. The involvement of various systems was seen in our study. The involvement of CNS (9.3%), Eye (7%), ENT (28%), GIT (20.9%), Urinary Tract (2.3%), Musculoskeletal System (35%), Gentialia (7%), CVS (7%).Conclusions: Congenital malformation, one of the important causes of infant mortality and morbidity can be reduced by proper preconception care and level two anomaly scan. Congenital anomalies must be identified, as early diagnosis and surgical correction of malformed babies offer the best chance for survival.


Author(s):  
Shivani S. Vaidya ◽  
Sarita K. Sharma

Background: Cancer is the second most common cause of death after heart diseases and it accounted for 8.8 million deaths worldwide in 2015. The long course of treatment, repeated hospitalisations, and the side effects of chemotherapy along with the trauma of being diagnosed with cancer has a significant effect on psyche of cancer patient. Depression is the most frequent cancer related symptom and 15-25% of cancer patients are affected by depression. The aim of this study is to determine the levels of depression in cancer patients undergoing chemotherapy.Methods: Present cross-sectional study was conducted amongst cancer patients undergoing chemotherapy at Day Care Centre, Department of Radiation Therapy and Oncology, Government Medical College and Hospital, Nagpur. 95 participants were interviewed using predesigned and pretested questionnaire based on the Beck’s Depression Inventory.Results: Among the study subjects, 70 (73.69%) had depression of which 15 (21.42%) had borderline clinical depression, 44 (62.85%) had moderate depression and 11 (15.73%) had severe depression. None of the study subjects had extreme depression.Conclusions: Majority of the study subjects receiving chemotherapy were depressed.


Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  

Author(s):  
Nandini Chatterjee ◽  
Supratick Chakraborty ◽  
Mainak Mukhopadhyay ◽  
Sinjon Ghosh ◽  
Bikramjit Barkandaj ◽  
...  

2020 ◽  
Vol 32 (1) ◽  
Author(s):  
Nearmeen M. Rashad ◽  
Marwa G. Amer ◽  
Waleed M. Reda Ashour ◽  
Hassan M. Hassanin

Abstract Background Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with varied clinical features. Disease-modifying drugs (DMDs) of MS associated with different types of thyroiditis. In this cross-sectional study, we aimed to assess the prevalence of thyroid dysfunction in MS and to investigate the association between DMDs and the risk of thyroiditis in MS. A cross-sectional study included 100 patients with relapsing-remitting multiple sclerosis (RRMS) in relapse, and the diagnosed was according to revised McDonald’s criteria 2010. Results Our results revealed that the prevalence of thyroiditis was 40%; autoimmune (34%) and infective (6%) among patients with RRMS in relapse and cerebellar symptoms were significantly higher in patients with thyroiditis compared to patients without thyroiditis. Regarding the association between DMDs and thyroiditis, the prevalence of patients treated with interferon-beta-1b was higher in MS patients with thyroiditis compared to MS patients without thyroiditis. However, the prevalence of patients treated with interferon-beta-1a was lower in MS patients with thyroiditis compared to MS patients without thyroiditis. In addition, we found CMV infection was more common in patients treated by interferon beta-1b and candida infection was common in patients treated by fingolimod. Conclusions Thyroiditis is commonly observed in patients with RRMS in relapse and higher prevalence of patients treated with interferon-beta-1b which is commonly associated with thyroiditis and CMV infection; however, candida thyroid infection was common in MS patients treated by fingolimod.


Sign in / Sign up

Export Citation Format

Share Document